UK markets closed

Sensei Biotherapeutics, Inc. (SNSE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.7900+0.1400 (+8.48%)
At close: 04:00PM EDT
1.7600 -0.03 (-1.68%)
After hours: 07:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,299
18,299
30,383
21,662
11,185
Selling general and administrative
18,765
18,765
19,805
15,820
7,528
Total operating expenses
37,064
37,064
50,188
37,482
18,713
Operating income or loss
-37,064
-37,064
-50,188
-37,482
-18,713
Interest expense
144
144
219
670
1,689
Total other income/expenses net
-517
-517
36
558
302
Income before tax
-34,101
-34,101
-48,588
-36,794
-20,100
Income from continuing operations
-34,101
-34,101
-48,588
-36,794
-20,100
Net income
-34,101
-34,101
-48,588
-36,794
-20,100
Net income available to common shareholders
-34,101
-34,101
-48,588
-36,794
-20,204
Basic EPS
-1.32
-1.22
-1.58
-1.33
-0.68
Diluted EPS
-1.32
-1.22
-1.58
-1.33
-0.68
Basic average shares
29,393
27,953
30,703
27,711
29,558
Diluted average shares
29,393
27,953
30,703
27,711
29,558